Navigation Links
Novavax CEO to Present at Oppenheimer 19th Annual Healthcare Conference
Date:10/29/2008

ROCKVILLE, Md., Oct. 29 /PRNewswire-FirstCall/ -- Novavax, Inc. (Nasdaq: NVAX) a clinical-stage vaccine company, announced today that Dr. Rahul Singhvi, President and Chief Executive Officer, will be presenting at the Oppenheimer 19th Annual Healthcare Conference at 12:00 pm. (EST) on November 4, 2008 at the Waldorf-Astoria Hotel, New York city. Dr. Singhvi will provide an overview of the company's strategy, research and development progress. A link to the live presentation can be accessed via the Company website at http://www.novavax.com. An archive of the presentation will be available one hour after the event on the Novavax website for 90 days.

ABOUT NOVAVAX

Novavax, Inc. (Nasdaq: NVAX) is a clinical stage biotechnology company, creating novel vaccines to address a broad range of infectious diseases worldwide using advanced proprietary virus-like particle (VLP) technology. The Company produces these VLP based, potent, recombinant vaccines utilizing new and efficient manufacturing approaches. Additional information about Novavax is available at http://www.novavax.com and in the Company's various filings with the Securities and Exchange Commission.


'/>"/>
SOURCE Novavax, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related biology technology :

1. Novavax CEO to Present at BIO CEO & Investor Conference
2. Novavax Enters Into Estrasorb(R) Asset Sale and Supply Agreements with Graceway Pharmaceuticals, LLC
3. Graceway Pharmaceuticals, LLC(TM) Announces Completed Acquisition of All Assets Related to Estrasorb(R) Product Line in North America From Allergan, Inc. (NYSE: AGN) and Novavax, Inc. (Nasdaq: NVAX)
4. Novavax CEO to Present at the World Vaccine Congress 2008
5. Novavax Opens Its First U.S. Vaccine Plant
6. Novavax Announces Release Date of 2008 First Quarter Financial Results and Investor Conference Call
7. Novavax Reports First Quarter 2008 Financial Results
8. Novavax CEO to Present at ACUMENBioFins 5th Annual Global Healthcare Conference
9. Novavax CEO to Present at FBR Capital Markets 12th Annual Spring Investor Conference
10. Novavax CEO to Present at Piper Jaffray Europe Conference, London, UK
11. Novavax to Join Russell 3000 Index

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)..., BEIJING, Nov. 25 /PRNewswire-Asia/ -- Sin...provider of vaccines, announced today that it exec...inovac (Dalian) Vaccine,Technology Co., Ltd. (Sino...e,and commercialize human-use vaccines. Sinovac wi...loping and commercializing world-class vaccines; t...
(Date:11/25/2009)...AN DIEGO, Nov. 25 Ardea ... that Barry D. Quart, Pharm.D., president and chie...fray 21st Annual Health Care Conference. , ,Prese...t Annual Health Care Conference,Date: Tuesday...me,Location: The New York Palace Hotel, New York,...
(Date:11/24/2009)..., HOUSTON, Nov. 24 IES (...ectrical and communications systems and services f...ets, announced today that its commercial business ...orcon JV to install the electrical systems for the...ty at the U.S. Army Medical Research Institute of ...
(Date:11/24/2009)... The New York investment bank KTA Capit...as agreed an AU$6.7 mil convertible note private p...rivate placement was arranged by KTA Capital as Ne... New York (PRWEB) November 2...k KTA Capital, LLC ("KTA Capital") has a...
Breaking Biology Technology:Sinovac Establishes Joint Venture to Expand Human-Use Vaccine Development and Manufacturing Capabilities 2Sinovac Establishes Joint Venture to Expand Human-Use Vaccine Development and Manufacturing Capabilities 3Ardea Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference 2Integrated Electrical Services Awarded Contract to Provide Electrical Systems for U.S. Army Medical Research Institute of Infectious Diseases 2KTA Capital Arranges an AU$6.7 Million Private Placement by Neuren Pharmaceuticals 2
...any Licenses Septin-9 DNA Methylation Biomarker fr...gnostics,Incorporated (NYSE: DGX ), the leading p...ices, today announced that it has licensed rights ...from Epigenomics AG,(Frankfurt, Prime Standard: EC...lop a molecular-based laboratory test that can hel...
...YORK, Feb. 19 Cowen Group, Inc. (Nasdaq:,COWN) an...nced today that,Matthew Q. Reber has been hired as...r is based in Connecticut and rejoins founders Gre...the Managing Directors of CHRP,with whom he previo...oining CHRP, Mr. Reber worked at Accretive LLC, a ...
...ARBOR, Mich., Feb. 19 MichBio, the association fo... chairman and chief,executive officer of Allegan, ...or its April 22 Annual Meeting in Ann Arbor. Papa,...for Quality, Affordable Healthcare,Products.", Pa... chief executive,officer. He was elected to the co...
Other Biology Technology:Quest Diagnostics to Develop Blood Test to Aid in the Detection of Colorectal Cancer 2Quest Diagnostics to Develop Blood Test to Aid in the Detection of Colorectal Cancer 3Quest Diagnostics to Develop Blood Test to Aid in the Detection of Colorectal Cancer 4Cowen Group, Inc. and Cowen Healthcare Royalty Partners Announce Expansion of Royalty Investment Team 2MichBio Announces Annual Meeting Keynote and Pre-Meeting Workshop 2
(Date:11/26/2009)...itehead researchers have developed a new type of g... genes and proteins used by pathogens, according t... cultures genes are present in two copies: one inh...ne inactivation by mutation is therefore inefficie...d copy usually remains active and takes over. , ...
(Date:11/25/2009)...ch, may be used to boost resistance to, or slow, t... of Medicine researchers report in a study publish...ce . , Parkinson,s disease is caused by a degene...ain known as the substantia nigra, which is respon... of dopamine in late-stage Parkinson,s causes symp...
(Date:11/25/2009)...the linchpin of the environment, where atmosphere,...ny students see soil as "just dirt" a place to gr...s are challenged with the task of helping students...of soil in the environment. , A collaborative p...at University of Nebraska-Lincoln, Oregon State Un...
Breaking Biology News(10 mins):Knockouts in human cells point to pathogenic targets 2Hormone ghrelin can boost resistance to Parkinson's disease 2It's not just dirt! 2National Alliance for Hispanic Health President and CEO Applauds House Action Calls on Senate to Pass Health Reform in 2009 60914 1National Alliance for Hispanic Health President and CEO Applauds House Action Calls on Senate to Pass Health Reform in 2009 60914 2PhRMA Statement on House Passage of Health Care Reform Bill 60912 1PhRMA Statement on House Passage of Health Care Reform Bill 60912 2PhRMA Statement on House Passage of Health Care Reform Bill 60912 3Stupak Amendment Passes in Final House Health Care Bill A First Step to Victory but Many Battles Ahead We Must Rejoice With Caution 60910 1
... CHICAGO -- A spinal cord injury often leads to pe...site of the injury because the damaged nerve fiber... the capacity to grow again, but dont because they...e injury. , Northwestern University researchers ...s the formation of scar tissue at the injury site ...
... This release is available in German . , , Hal... with nitrogen could be lowered in future. Soil sc... Research (UFZ) have developed a new mathematical ...ons for microbiological water treatment. Using the...tical model, which is the most accurate to date, c...
... The bombardier beetle is inspiring designers of e...rs to improve spray technologies, writes Andy McIn...f Swedish Biomimetics 3000 Ltd, in Aprils Physics ...frica and Asia, is remarkable in that it can fire ...edators such as birds and frogs. While the chemic...
Other Biology News:Promising new nanotechnology for spinal cord injury 2New formula for combating the greenhouse gas nitrous oxide 2New formula for combating the greenhouse gas nitrous oxide 3New formula for combating the greenhouse gas nitrous oxide 4The bombardier beetle, power venom and spray technologies 2
Equine TNF-alpha / TNFSF1A, Unconjugated from R&D Systems
...ng Checker Kits provide two highly efficient metho...formation without time-consuming plasmid preparati...I, all you need to do is to transfer partial colon...mation plates into the solutions provided by the k...
GRADIENT MAKER, 30 ML from GE Healthcare, formerly Amersham Biosciences
...and G. Butcher (1998). • The major histocompa...n the immunology area. There is great interest in ...n as antigen-presenting molecules. Many immunology...biochemical and genetic techniques in order to stu...
Biology Products: